The capital turnover (annual revenue relative to shareholder's equity) for TAT is -2.66 -- better than merely 3.75% of US stocks.
Equity multiplier, or assets relative to shareholders' equity, comes in at -56.59 for Transatlantic Petroleum Ltd; that's greater than it is for merely 0.54% of US stocks.
Transatlantic Petroleum Ltd's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 114.86%, greater than the shareholder yield of 97.02% of stocks in our set.
Stocks that are quantitatively similar to TAT, based on their financial statements, market capitalization, and price volatility, are QTNT, SQNS, OMEX, UI, and PLX.
Below please find a table outlining a discounted cash flow forecast for TAT, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Transatlantic Petroleum Ltd ranked in the 50th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 15.83% on a DCF basis. The most interesting components of our discounted cash flow analysis for Transatlantic Petroleum Ltd ended up being:
The company's compound free cash flow growth rate over the past 4.37 years comes in at -0.22%; that's greater than merely 6.97% of US stocks we're applying DCF forecasting to.
As a business, TAT is generating more cash flow than merely 18.25% of positive cash flow stocks in the Energy.
Transatlantic Petroleum Ltd's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -2.36. This coverage rate is greater than that of just 16.06% of stocks we're observing for the purpose of forecasting via discounted cash flows.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
Want more companies with a valuation profile/forecast similar to that of Transatlantic Petroleum Ltd? See HAL, DCP, DLNG, EOG, and EPD.
NEW YORK, Aug. 10, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of TransAtlantic Petroleum Ltd. ("TAT" or the "Company") (NYSE American: TAT) in connection with the proposed interested-party…
Gainers Mexco Energy Corporation (NYSE: MXC ) shares rose 201.7% to $10.50 in pre-market trading after jumping over 18% on Tuesday. TransAtlantic Petroleum Ltd. (NYSE: TAT ) rose 123.5% to $0.7005 in pre-market trading following a 23% surge in the previous session. Oblong Inc. (NYSE: OBLG ) rose 53% to $3.78 in pre-market trading after declining 12% on Tuesday. U.S. Energy Corp. (NASDAQ: USEG ) shares rose 43% to $7.16 in pre-market trading after gaining around 6% on Tuesday. Barnwell Industries, Inc. (NYSE: BRN ) rose 41.5% to $1.38 in pre-market trading after surging around 10% on Tuesday. Atossa Therapeutics, Inc. (NASDAQ: ATOS ) rose 25.7% to $4.65 in pre-market trading. Avance Clinical has been contracted for Atossa Therapeutics’ AT-301 nasal spray clinical study. Intec Pharma Ltd....